338 related articles for article (PubMed ID: 23687261)
21. Comorbidities (excluding lymphoma) in Sjögren's syndrome.
Pego-Reigosa JM; Restrepo Vélez J; Baldini C; Rúa-Figueroa Fernández de Larrinoa Í
Rheumatology (Oxford); 2021 May; 60(5):2075-2084. PubMed ID: 30770715
[TBL] [Abstract][Full Text] [Related]
22. Association between primary Sjögren's syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis.
Yong WC; Sanguankeo A; Upala S
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):190-197. PubMed ID: 29600936
[TBL] [Abstract][Full Text] [Related]
23. Incidence of cancer in a cohort of patients with primary Sjögren syndrome in Argentina.
Brom M; Moyano S; Gandino IJ; Scolnik M; Soriano ER
Rheumatol Int; 2019 Oct; 39(10):1697-1702. PubMed ID: 31471716
[TBL] [Abstract][Full Text] [Related]
24. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome.
Baldini C; Pepe P; Luciano N; Ferro F; Talarico R; Grossi S; Tavoni A; Bombardieri S
J Rheumatol; 2012 Apr; 39(4):804-8. PubMed ID: 22337248
[TBL] [Abstract][Full Text] [Related]
25. Association between primary Sjögren's syndrome and pregnancy complications: a systematic review and meta-analysis.
Upala S; Yong WC; Sanguankeo A
Clin Rheumatol; 2016 Aug; 35(8):1949-1955. PubMed ID: 27271701
[TBL] [Abstract][Full Text] [Related]
26. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
[TBL] [Abstract][Full Text] [Related]
27. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
28. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases.
Alani H; Henty JR; Thompson NL; Jury E; Ciurtin C
Scand J Rheumatol; 2018 Mar; 47(2):141-154. PubMed ID: 28927315
[TBL] [Abstract][Full Text] [Related]
29. Depression in primary Sjögren's syndrome: a systematic review and meta-analysis.
Cui Y; Li L; Yin R; Zhao Q; Chen S; Zhang Q; Shen B
Psychol Health Med; 2018 Feb; 23(2):198-209. PubMed ID: 28621153
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary nodules in patients with primary Sjögren's syndrome: Causes, clinico-radiologic features, and outcomes.
Casal Moura M; Navin PJ; Johnson GB; Hartman TE; Baqir M; Yi ES; Ryu JH
Respir Med; 2020; 174():106200. PubMed ID: 33147563
[TBL] [Abstract][Full Text] [Related]
31. Primary Sjogren's syndrome and the risk of acute pancreatitis: a nationwide cohort study.
Chang CC; Chang YS; Wang SH; Lin SY; Chen YH; Chen JH
BMJ Open; 2017 Aug; 7(8):e014807. PubMed ID: 28801391
[TBL] [Abstract][Full Text] [Related]
32. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome.
Pariente D; Anaya JM; Combe B; Jorgensen C; Emberger JM; Rossi JF; Sany J
Eur J Med; 1992 Oct; 1(6):337-42. PubMed ID: 1341461
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication.
Badarinza M; Serban O; Maghear L; Pelea MA; Rosca RI; Fodor D; Stancu B
Med Clin (Barc); 2023 Jun; 160(11):484-488. PubMed ID: 37005121
[TBL] [Abstract][Full Text] [Related]
34. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
35. Anti-citrullinated protein antibodies and arthritis in Sjögren's syndrome: a systematic review and meta-analysis.
Molano-González N; Olivares-Martínez E; Anaya JM; Hernández-Molina G
Scand J Rheumatol; 2019 Mar; 48(2):157-163. PubMed ID: 30270696
[TBL] [Abstract][Full Text] [Related]
36. Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database.
Goulabchand R; Malafaye N; Jacot W; Witkowski Durand Viel P; Morel J; Lukas C; Rozier P; Lamure S; Noel D; Molinari N; Mura T; Guilpain P
Autoimmun Rev; 2021 Dec; 20(12):102987. PubMed ID: 34718160
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.
Beltai A; Barnetche T; Daien C; Lukas C; Gaujoux-Viala C; Combe B; Morel J
Arthritis Care Res (Hoboken); 2020 Jan; 72(1):131-139. PubMed ID: 30570824
[TBL] [Abstract][Full Text] [Related]
38. A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects.
Pertovaara M; Pukkala E; Laippala P; Miettinen A; Pasternack A
Ann Rheum Dis; 2001 May; 60(5):467-72. PubMed ID: 11302868
[TBL] [Abstract][Full Text] [Related]
39. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
[TBL] [Abstract][Full Text] [Related]
40. Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional study.
Zhang Y; Li M; Zhang L; Li Q; Yang P; Kong X; Duan X; Zhang M; Li X; Wang Y; Xu J; Wang Y; Hsieh E; Zhao J; Xu D; Zhao Y; Zeng X
Clin Rheumatol; 2020 Sep; 39(9):2677-2688. PubMed ID: 32146615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
